AtriCure Stock

AtriCure Forward P/E

The Forward P/E Ratio of AtriCure (ATRC) as of Aug 12, 2026 is -141.79. In the previous year, Forward P/E Ratio was -36.32 — a change of 290.44% (lower).

Forward P/E

-141.79

YoY

290.44%

Last updated:

Forward P/E Ratio of AtriCure is 2026 -141.79 . Forward P/E Ratio of AtriCure was 2025 -36.32 . It decreases by 290.44% lower compared to the previous year.
Access this data via the Eulerpool API

AtriCure Stock analysis

What does AtriCure do? AtriCure Inc is a medical technology company that specializes in the development of innovative products and therapies for the treatment of cardiac arrhythmias. It was founded in 2000 and is headquartered in Mason, Ohio, USA. The company offers a wide range of products and therapies, including the isolation of pulmonary veins, catheter technology, radiofrequency ablation, and innovative solutions for the treatment of heart valve diseases and other structural heart problems. AtriCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AtriCure stock

Forward P/E Ratio of AtriCure is -141.79 in 2026.

Forward P/E Ratio of AtriCure changed from -36.32 to -141.79, representing a 290.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio AtriCure since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's AtriCure with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — AtriCure

All Key Metrics — AtriCure